Exploiting signaling rewiring in cancer cells with co‐existing oncogenic drivers
The development of tailored therapies designed to specifically target driver oncogenes has initiated a revolutionary era in cancer biology. The availability of a growing number of selective inhibitors has generated novel experimental and clinical paradigms. These represent an opportunity and a chall...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2023-11-01
|
| coleção: | Molecular Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/1878-0261.13547 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|